XERS
Xeris Pharmaceuticals Inc
NASDAQ: XERS · HEALTHCARE · BIOTECHNOLOGY
$6.13
+1.74% today
Updated 2026-04-30
Market cap
$1.04B
P/E ratio
0.00
P/S ratio
3.56x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$4 – $10
Volume
1.9M
Xeris Pharmaceuticals Inc (XERS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |